September 27, 2010 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for the first 2 fully automated gliadin tests with deamidated peptides (EliA GliadinDP IgA and EliA ...

The recent detection of antibodies in celiac patients specific for deamidated gliadin peptides (DGP), the product of tTG binding to gliadin peptides, provides an opportunity to address the correlation ...

Celiac disease (CD) is caused by loss of tolerance toward gluten and related cereal products. The delivery of gliadin peptides (GP) to HLA-DR-positive late endosomes (LE) of enterocytes is required ...

Gluten consumption has previously been implicated in the development of schizophrenia while an immunological link between gluten and schizophrenia was established by the detection of circulating ...

Background: The objective of this study was to compare celiac disease (CD)– specific antibody tests to determine if they could replace jejunal biopsy in patients with a high pretest probability of CD.

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, ...

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, ...

This is a preview. Log in through your library . Abstract Coeliac disease is diagnosed by means of jejunal biopsy, an invasive procedure. Anti-gliadin antibodies (AGA) have therefore been used in the ...

Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science communities, released ZediXclusive TG6-ab ELISA (IgA), the updated ...

Celiac disease affects 0.3-2.4% of people in most countries world-wide, and approx. 2% in Finland. Celiac patients suffer from a variety of symptoms, typically intestinal complaints, such as diarrhea, ...

Nanoparticles containing gliadin could lead to the cure of celiac disease where patients may then be able to eat normal food again without harmful consequences, says a new study. Nanoparticles ...